Ketorolac Tromethamine
Rank #469 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.6M
Total Cost
582,750
Total Claims
$15.6M
Total Cost
7,398
Prescribers
$27
Cost per Claim
355,547
Beneficiaries
677,157
30-Day Fills
$2,111
Avg Cost/Provider
79
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.6M total
Top Prescribers of Ketorolac Tromethamine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | James Woodmansee | Family Practice | Provo, UT | 13 | $137K |
| 2 | Russell Abrams | Neurology | Cherry Hill, NJ | 41 | $108K |
| 3 | Faisel Ahmad | Ophthalmology | Marion, IL | 2,227 | $51K |
| 4 | Mark Fromer | Ophthalmology | New York, NY | 1,794 | $47K |
| 5 | James Gills | Ophthalmology | Tarpon Springs, FL | 1,745 | $44K |
| 6 | Kimberly Ireland | Ophthalmology | Summit, WI | 1,460 | $42K |
| 7 | Thao Thach | Ophthalmology | Garland, TX | 595 | $38K |
| 8 | Karen Brown | Physician Assistant | Fairfield, CT | 14 | $38K |
| 9 | Carol Lee-Faust | Ophthalmology | Tempe, AZ | 567 | $36K |
| 10 | Thomas Robertson | Ophthalmology | Rocky Mount, NC | 1,298 | $35K |
| 11 | Sebastian Heersink | Ophthalmology | Dothan, AL | 1,273 | $35K |
| 12 | Jeffrey Bunning | Ophthalmology | Bristol, TN | 1,180 | $31K |
| 13 | Joseph Selem | Ophthalmology | Coral Gables, FL | 1,153 | $31K |
| 14 | Edward Wade | Ophthalmology | Bellaire, TX | 1,190 | $31K |
| 15 | John Vinh | Optometry | National City, CA | 617 | $30K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology